These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24440968)

  • 1. Salmonella vaccines: lessons from the mouse model or bad teaching?
    Strugnell RA; Scott TA; Wang N; Yang C; Peres N; Bedoui S; Kupz A
    Curr Opin Microbiol; 2014 Feb; 17():99-105. PubMed ID: 24440968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nontyphoidal salmonella disease: Current status of vaccine research and development.
    Tennant SM; MacLennan CA; Simon R; Martin LB; Khan MI
    Vaccine; 2016 Jun; 34(26):2907-2910. PubMed ID: 27032517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines.
    Boyd MA; Tennant SM; Saague VA; Simon R; Muhsen K; Ramachandran G; Cross AS; Galen JE; Pasetti MF; Levine MM
    Clin Vaccine Immunol; 2014 May; 21(5):712-21. PubMed ID: 24623629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines for typhoid fever and other salmonelloses.
    Martin LB
    Curr Opin Infect Dis; 2012 Oct; 25(5):489-99. PubMed ID: 22825288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine value profile for invasive non-typhoidal Salmonella disease.
    Martin LB; Tack B; Marchello CS; Sikorski MJ; Owusu-Dabo E; Nyirenda T; Mogasale V; Crump JA
    Vaccine; 2024 Jul; 42(19S1):S101-S124. PubMed ID: 39003017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmonella Typhi, Paratyphi A, Enteritidis and Typhimurium core proteomes reveal differentially expressed proteins linked to the cell surface and pathogenicity.
    Saleh S; Van Puyvelde S; Staes A; Timmerman E; Barbé B; Jacobs J; Gevaert K; Deborggraeve S
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007416. PubMed ID: 31125353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple immunodominant O-epitopes co-expression in live attenuated Salmonella serovars induce cross-protective immune responses against S. Paratyphi A, S. Typhimurium and S. Enteritidis.
    Li P; Zhang K; Lei T; Zhou Z; Luo H
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010866. PubMed ID: 36228043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomic analysis between typhoidal and non-typhoidal Salmonella serovars reveals typhoid-specific protein families.
    Zou QH; Li RQ; Liu GR; Liu SL
    Infect Genet Evol; 2014 Aug; 26():295-302. PubMed ID: 24951835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of OmpL as a potential vaccine candidate for immune-protection against salmonellosis in mice.
    Yang Y; Wan C; Xu H; Wei H
    Vaccine; 2013 Jun; 31(28):2930-6. PubMed ID: 23643894
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Gasperini G; Massai L; De Simone D; Raso MM; Palmieri E; Alfini R; Rossi O; Ravenscroft N; Kuttel MM; Micoli F
    Front Cell Infect Microbiol; 2024; 14():1347813. PubMed ID: 38487353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse models to assess the efficacy of non-typhoidal Salmonella vaccines: revisiting the role of host innate susceptibility and routes of challenge.
    Simon R; Tennant SM; Galen JE; Levine MM
    Vaccine; 2011 Jul; 29(32):5094-106. PubMed ID: 21616112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for prevention of Salmonella infection in children through vaccination.
    McGregor AC; Waddington CS; Pollard AJ
    Curr Opin Infect Dis; 2013 Jun; 26(3):254-62. PubMed ID: 23591641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic determinants and polymorphisms specific for human-adapted serovars of Salmonella enterica that cause enteric fever.
    Tracz DM; Tabor H; Jerome M; Ng LK; Gilmour MW
    J Clin Microbiol; 2006 Jun; 44(6):2007-18. PubMed ID: 16757591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines against invasive Salmonella disease: current status and future directions.
    MacLennan CA; Martin LB; Micoli F
    Hum Vaccin Immunother; 2014; 10(6):1478-93. PubMed ID: 24804797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing rates of Salmonella Paratyphi A and the current status of its vaccine development.
    Sahastrabuddhe S; Carbis R; Wierzba TF; Ochiai RL
    Expert Rev Vaccines; 2013 Sep; 12(9):1021-31. PubMed ID: 24053396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-Serotype Conversion in
    Li P; Liu Q; Luo H; Liang K; Yi J; Luo Y; Hu Y; Han Y; Kong Q
    Front Immunol; 2017; 8():1647. PubMed ID: 29255460
    [No Abstract]   [Full Text] [Related]  

  • 19. The global burden and epidemiology of invasive non-typhoidal
    Balasubramanian R; Im J; Lee JS; Jeon HJ; Mogeni OD; Kim JH; Rakotozandrindrainy R; Baker S; Marks F
    Hum Vaccin Immunother; 2019; 15(6):1421-1426. PubMed ID: 30081708
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Hanumunthadu B; Kanji N; Owino N; Ferreira Da Silva C; Robinson H; White R; Ferruzzi P; Nakakana U; Canals R; Pollard AJ; Ramasamy M;
    BMJ Open; 2023 Nov; 13(11):e072938. PubMed ID: 37963701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.